Mecanismo de accin paso a paso Cuando se administra un agonista del receptor de GLP-1 (normalmente mediante inyeccin subcutnea semanal), el frmaco se une a los mismos receptores que la hormona natural produciendo una respuesta amplificada y sostenida: Mayor liberacin de insulina , mejorando el control glucmico sin provocar hipoglucemias
These medications mimic a natural hormone produced in the intestines, helping to lower blood glucose, boost insulin production, and slow down digestion
For example, From a drug-development perspective, METRNL illustrates the limitations of receptor-centric paradigms
GLP-1 medications can be incredibly effective tools, but they work best when paired with habits that support long-term health, not just short-term weight loss
Amberly Johnson is the director of the Utah Poison Control Center